The trajectory of copyright's flagship drug presents a nuanced case for stakeholders in the medicinal sector. While initially a phenomenal success, creating huge profits, the intellectual property lapse and the https://escort382834.blognody.com/51439185/the-little-copyright-and-big-pharma-a-risky-bet